Approval of First CAR-Ts: Have we Solved all Hurdles for ATMPs? (Q61811550)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32634192%20AND%20SRC:MED&resulttype=core&format=json

16 July 2020

Karl Heller

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32634192%20AND%20SRC:MED&resulttype=core&format=json

16 July 2020

Jan Richter

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32634192%20AND%20SRC:MED&resulttype=core&format=json

16 July 2020

publication date

January 2019

0 references

published in

Cell medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32634192%20AND%20SRC:MED&resulttype=core&format=json

16 July 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32634192%20AND%20SRC:MED&resulttype=core&format=json

16 July 2020

page(s)

2155179018822781

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32634192%20AND%20SRC:MED&resulttype=core&format=json

Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy

16 July 2020

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Current status of chimeric antigen receptor therapy for haematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Clinical manufacturing of CAR T cells: foundation of a promising therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Global Manufacturing of CAR T Cell Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

https://pubmed.ncbi.nlm.nih.gov/32634192

1 reference

12 December 2020

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

CAR-T cells: the long and winding road to solid tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

CAR T cell immunotherapy for human cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Emerging role of immunotherapy for childhood cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Expediting Drug Development: FDA's New Regenerative Medicine Advanced Therapy Designation

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

1 reference

https://pubmed.ncbi.nlm.nih.gov/32634192

12 December 2020

Identifiers

DOI

10.1177/2155179018822781

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32634192%20AND%20SRC:MED&resulttype=core&format=json

16 July 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32634192%20AND%20SRC:MED&resulttype=core&format=json

16 July 2020

PubMed publication ID

32634192

1 reference